

Medicare Part D: Competition and Generic Drug Prices, 2007-2018
The United States relies on the interactions of private entities – drug manufacturers, health plans and pharmaceutical benefit managers (PBMs) - to achieve value by negotiating prices, operating formularies and implementing other benefit management strategies.
Medicare Part D: Competition and Generic Drug Prices